Tonnes of medical waste including human organs, body parts and dangerous medical chemicals have been “stockpiled” by one of the NHS’s biggest disposal contractors, leaked documents have revealed.
HES, which made a £15.4m profit last year, claims that the UK’s “ageing incinerators and strict disposal policies” make it impossible to keep up with demand, leading to a “signifiant amount of excess waste being stored at its sites”, The Independent says.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In September, excess waste levels at the firm’s waste disposal plant in Normanton, West Yorkshire, reached 350 tonnes - “five times more than HES’s permitted level”, according to the HSJ report.
“This anatomical waste, which is made up of human body parts and surgical waste, has now been placed in fridges,” the news site continues, adding: “HES is also attempting to export 750 tonnes of pharmaceutical waste to Holland.”
The British government has said that the contractor’s practices do not pose a risk to the public.
But according to the leaked documents, 13 warning notices and two compliance notices have been issued to HES by the Environment Agency in the past year.
The government agency today announced that a criminal investigation has been launched.
According to HSJ, the waste stockpile was also discussed during a Cobra national incident committee meeting last month, when Health Secretary Matt Hancock ordered that £1m be set aside to help solve the problem.
Responding to the news of the stockpiled medical waste, shadow health secretary Jonathan Ashworth said: “These are staggering revelations and given the number of NHS trusts involved, along with wider environmental health implications, I’m disappointed the health secretary didn’t inform Parliament last month.”
Meanwhile, an HES spokesperson said: “We are working closely with our various disposal sites, including utilising our own £13m new waste to energy facility to reduce the volume on site, whilst maintaining services.”
-
August 23 editorial cartoonsCartoons Saturday's political cartoons include deficit dimness, steamroller-in-chief, and more
-
5 museum-grade cartoons about Trump's Smithsonian purgeCartoons Artists take on institutional rebranding, exhibit interpretation, and more
-
Settling the West Bank: a death knell for a Palestine state?In the Spotlight The reality on the ground is that the annexation of the West Bank is all but a done deal
-
How the care industry came to rely on migrant workersThe Explainer Government crackdown on recruiting workers abroad risks deepening care sector crisis, industry leaders warn
-
Could medics' misgivings spell the end of the assisted dying bill?Today's Big Question The Royal College of Psychiatrists has identified 'serious concerns' with the landmark bill – and MPs are taking notice
-
Washwood Heath: Birmingham's pioneering neighbourhood health serviceIn the Spotlight NHS England chair says there is a 'really good argument this is the model for the future'
-
The UK's first legal drug consumption roomThe Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
-
How can the UK solve the adult social care crisis?Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
-
Should blood donors be paid?The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
-
UK gynaecological care crisis: why thousands of women are left in painThe Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
-
A 'transformative' gene therapy for haemophilia BThe Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost
